ArticleFrontiers in medicine2026
Case Report: Pulmonary fibroleiomyomatous hamartoma presenting as a giant exophytic multilocular cystic lesion.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary fibroleiomyomatous hamartoma (PLH) is a rare benign subtype of pulmonary hamartoma. It typically presents on imaging as a well-circumscribed solid pulmonary nodule. The lesion can arise in any region of the lung. There is a slight female predominance, and most patients are asymptomatic or present with mild, non-specific respiratory symptoms such as cough and sputum production. In most cases, the lesion is incidentally detected during routine health examinations or imaging studies performed for unrelated conditions. This case report describes a 55-year-old woman in whom a cystic abnormal lesion with areas of air lucency was incidentally detected in the right upper lobe during a routine health examination. The lesion appeared as a large space-occupying mass with cystic wall enhancement on imaging, and a congenital cystic lesion was initially suspected. After admission, the patient underwent thoracoscopic wedge resection of the right upper lobe lesion. Intraoperatively, the tumor demonstrated a pedunculated exophytic growth pattern with a narrow stalk. Postoperative histopathological examination revealed a biphasic architecture composed of epithelial and mesenchymal components. Immunohistochemical findings, together with the histopathological features, favored the diagnosis of pulmonary fibroleiomyomatous hamartoma. The patient recovered uneventfully after surgery, and no evidence of recurrence was observed during the available follow-up period. To our knowledge, this is the first reported case describing a pulmonary lesion favoring the diagnosis of pulmonary fibroleiomyomatous hamartoma that presents predominantly as a giant exophytic multilocular cystic lesion. The patient had a previous history of hysterectomy for uterine leiomyoma, and the lesion showed positive expression of estrogen receptor (ER) and progesterone receptor (PR), suggesting a potential hormonal association. This case highlights that pulmonary fibroleiomyomatous hamartoma should be considered in the differential diagnosis of pulmonary lesions in female patients with a history of uterine leiomyoma, even when imaging findings demonstrate atypical cystic features, to reduce the risk of misdiagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.